Plasmagen Biosciences appoints Vivek V Kamath as Chief Executive Officer
Leadership change announced as company prepares for global expansion in plasma-derived medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eli Lilly to invest over $1 billion in contract manufacturing in India
New manufacturing & quality hub in Hyderabad to support global supply capabilities and recruitment drive
Union Health Secretary reviews drug quality and rational use of cough syrups with states and UTs
Central team investigates cough syrup-linked child deaths in Madhya Pradesh; States directed to ensure compliance with Schedule M…
India invites proposals under PRIP scheme to propel Pharma‑MedTech R&D projects
Programme offers funding support from idea to market across early and later stage projects, with enhanced incentives for strategic…
AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan
New indication approved for treatment of unresectable or metastatic HER2-positive solid tumours in adult patients after prior…
Lupin launches generic Liraglutide Injection in the U.S. market
New launch offers bioequivalent alternative to Victoza for type 2 diabetes management in adults and children aged 10 and above
FDA launches pilot program to prioritise review of U.S. made generic drug applications
New initiative offers faster ANDA reviews for companies using domestic manufacturing and testing to bolster U.S. pharma supply…
IPA announces leadership transition
Sharvil Patel, MD, Zydus Lifesciences and former VP, IPA, assumes the role of President,; Glenn Saldanha, Chairman and MD,…
Supriya Lifescience receives WHO GMP Certification for Ambernath Facility
Approval enables commercial production of formulations with projected revenue potential of ₹500 crore
AI compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…